Log In
BCIQ
Print this Print this
 

ABY-018

  Manage Alerts
Collapse Summary General Information
Company amp biosimilars AG
DescriptionHumanized mAb biosimlar of an undisclosed cancer product
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

05/28/2015

0

0

0

Get a free BioCentury trial today